In our Season 11 opening episode, we’re bringing you the latest updates from the 2025 ASCO Annual Meeting on metastatic breast cancer. Dr. Ashley Schreier, breast oncologist at Weill Cornell Medicine, breaks down key research and explains what it could mean for people living with MBC.
Topics include:
Research results for hormone therapy options like camizestrant
The role of ESR1 mutation testing
Results from treatment combinations like Enhertu and Perjeta, and Trodelvy and Keytruda
How to navigate clinical trial access
Tips for staying hopeful while exploring treatment options
Whether you’re a patient, caregiver, or advocate, this episode is packed with insights to help you stay informed and empowered.
We’re so happy you joined us! If this conversation resonated with you please share it with someone who might need it. Don't forget to like and subscribe here to follow us on your favorite podcast platform so you never miss an episode. You can find more episodes, resources and ways to get involved on our website Our MBC Life. Have a topic you’d like us to cover? Email us at ourmbclife@sharecancersupport.org. And don’t forget to follow us on our socials @ourmbclife.
Podden och tillhörande omslagsbild på den här sidan tillhör
SHARE Cancer Support. Innehållet i podden är skapat av SHARE Cancer Support och inte av,
eller tillsammans med, Poddtoppen.
